CA2206754C - Benzimidazole derivatives with antihistaminic activity - Google Patents

Benzimidazole derivatives with antihistaminic activity Download PDF

Info

Publication number
CA2206754C
CA2206754C CA002206754A CA2206754A CA2206754C CA 2206754 C CA2206754 C CA 2206754C CA 002206754 A CA002206754 A CA 002206754A CA 2206754 A CA2206754 A CA 2206754A CA 2206754 C CA2206754 C CA 2206754C
Authority
CA
Canada
Prior art keywords
ethyl
benzimidazole
piperidine
phenyl
accordance
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CA002206754A
Other languages
English (en)
French (fr)
Other versions
CA2206754A1 (en
Inventor
Aurelio Orjales
Victor Rubio
Maravillas Bordell
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Faes Farma SA
Original Assignee
Faes Farma SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Faes Farma SA filed Critical Faes Farma SA
Publication of CA2206754A1 publication Critical patent/CA2206754A1/en
Application granted granted Critical
Publication of CA2206754C publication Critical patent/CA2206754C/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pulmonology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
CA002206754A 1996-06-04 1997-06-03 Benzimidazole derivatives with antihistaminic activity Expired - Lifetime CA2206754C (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ESP9601236 1996-06-04
ES09601236A ES2124167B1 (es) 1996-06-04 1996-06-04 Nuevos derivados del bencimidazol con actividad antihistaminica.

Publications (2)

Publication Number Publication Date
CA2206754A1 CA2206754A1 (en) 1997-12-04
CA2206754C true CA2206754C (en) 2007-01-23

Family

ID=8295035

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002206754A Expired - Lifetime CA2206754C (en) 1996-06-04 1997-06-03 Benzimidazole derivatives with antihistaminic activity

Country Status (27)

Country Link
US (1) US5877187A (en:Method)
EP (1) EP0818454B1 (en:Method)
JP (1) JP4218991B2 (en:Method)
CN (1) CN1105716C (en:Method)
AR (1) AR008386A1 (en:Method)
AT (1) ATE264317T1 (en:Method)
AU (1) AU725700B2 (en:Method)
BR (1) BR9703276A (en:Method)
CA (1) CA2206754C (en:Method)
CZ (1) CZ289278B6 (en:Method)
DE (2) DE122011000006I1 (en:Method)
DK (1) DK0818454T3 (en:Method)
ES (1) ES2124167B1 (en:Method)
FR (1) FR11C0023I2 (en:Method)
HR (1) HRP970307B1 (en:Method)
HU (1) HU227598B1 (en:Method)
IN (1) IN186319B (en:Method)
LU (1) LU91798I2 (en:Method)
MX (1) MXPA97004127A (en:Method)
NO (2) NO313195B1 (en:Method)
PL (1) PL188908B1 (en:Method)
PT (1) PT818454E (en:Method)
RU (1) RU2182150C2 (en:Method)
SI (1) SI0818454T1 (en:Method)
TR (1) TR199700464A3 (en:Method)
TW (1) TW438794B (en:Method)
ZA (1) ZA974893B (en:Method)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ID29247A (id) 1998-07-01 2001-08-16 Takeda Chemical Industries Ltd Bahan pengatur fungsi reseptor retinoid
CN1184208C (zh) 1998-11-27 2005-01-12 巴斯福股份公司 取代的苯并咪唑及其制备和用途
ES2151442B1 (es) * 1999-01-11 2001-07-01 Espanola Prod Quimicos Nuevo derivado del bencenoetanol.
US6826561B2 (en) 2000-05-22 2004-11-30 Broadcom Corporation Method and apparatus for performing a binary search on an expanded tree
WO2003089425A1 (es) * 2002-04-19 2003-10-30 Faes Farma, S.A. POLIMORFO DEL ÁCIDO 4-[2-[4-[1-(2-ETOXIETIL)-1H-BENCIMIDAZOL-2-IL]-1-PIPERIDINIL]ETIL]-α, α-DIMETIL-BENCENOACÉTICO
RU2288917C2 (ru) * 2002-04-19 2006-12-10 Фаэс Фарма, С.А. Полиморф 4-[2-[4-[1-(2-этоксиэтил)-1h-бензимидазол-2-ил]-1-пиперидинил]этил]-альфа, альфа-диметилбензолуксусной кислоты, способ его получения, фармацевтический препарат на его основе и его применение
KR101052433B1 (ko) * 2002-06-13 2011-07-29 버텍스 파마슈티칼스 인코포레이티드 자이라제 및/또는 토포이소머라제 ⅳ 억제제로서의 2-우레이도-6-헤테로아릴-3ｈ-벤조이미다졸-4-카복실산 유도체 및 이를 포함하는 세균 감염 치료용 약제학적 조성물
US20070188330A1 (en) * 2006-01-24 2007-08-16 Morhard Robert C System and method for detecting, monitoring, tracking and identifying explosive materials using ID marks
US7247623B2 (en) * 2005-08-19 2007-07-24 Inspire Pharmaceuticals, Inc. Method of treating dry eye disease with non-drying antihistamines
WO2009102155A2 (en) * 2008-02-12 2009-08-20 Yuhan Corporation Process for preparation of 2-methyl-2´-phenylpropionic acid derivatives and novel intermediate compounds
JP2010013472A (ja) * 2009-09-09 2010-01-21 Faes Farma Sa ４−［２−［１−（２−エトキシエチル）−１Ｈ−ベンズイミダゾール−２−イル］−１−ピペリジニル］エチル］−α，α−ジメチルベンゼノ酢酸の多形体
CN102675101B (zh) * 2012-05-16 2014-01-29 王蕾 2-(4-卤乙基)苯基-2-甲基丙酸酯的制备方法及合成比拉斯汀的方法
CZ307500B6 (cs) 2012-08-15 2018-10-24 Zentiva, K.S. Způsob přípravy derivátu 2-methyl-2´-fenylpropionové kyseliny využívající nové intermediáty
KR102066476B1 (ko) * 2013-03-15 2020-01-15 허큘레스 엘엘씨 개선된 침적 특성을 가진 조성물 및 개선된 침적 특성을 가진 개인 관리 조성물의 제조 방법
CN103214455B (zh) * 2013-03-30 2018-08-31 北京万全德众医药生物技术有限公司 一种比拉斯汀的制备方法
CN103214454A (zh) * 2013-03-30 2013-07-24 北京万全德众医药生物技术有限公司 一种比拉斯汀晶型及制备方法
WO2014188453A2 (en) * 2013-05-24 2014-11-27 Msn Laboratories Private Limited Novel process for the preparation of 2-[4-(2-{4-[1-(2-ethoxyethyl)-1h-benzimidazol-2-yl]-1-piperidinyl}ethyl) phenyl]-2-methylpropanoic acid
CN103351380B (zh) * 2013-06-30 2019-01-22 北京万全德众医药生物技术有限公司 一种制备比拉斯汀的方法
CN104447683A (zh) * 2013-09-12 2015-03-25 天津市汉康医药生物技术有限公司 一种稳定的比拉斯汀化合物
CN103896915A (zh) * 2014-04-01 2014-07-02 中国药科大学 苯并咪唑类衍生物、其制备方法及其在医药上的应用
EP3040334A1 (en) 2014-12-29 2016-07-06 Faes Farma, S.A. New benzimidazole derivatives as antihistamine agents
CN106349214B (zh) * 2015-07-13 2020-11-03 南京长澳医药科技有限公司 一种比拉斯汀杂质的制备方法
PT3327012T (pt) * 2015-07-24 2021-06-21 Disproquima S A Formas cristalinas de bilastina e os seus métodos de preparação
CN105272977A (zh) * 2015-09-19 2016-01-27 万全万特制药江苏有限公司 一种制备比拉斯汀中间体的方法
EP3170817A1 (en) 2015-11-20 2017-05-24 Faes Farma, S.A. Co-crystals of benzimidazole compounds
EP3170816A1 (en) 2015-11-20 2017-05-24 Faes Farma, S.A. Supersaturated compositions of benzimidazole compounds
WO2017167949A1 (en) 2016-04-01 2017-10-05 Krka, D.D., Novo Mesto Crystalline forms of bilastine
WO2017191651A1 (en) * 2016-05-05 2017-11-09 Msn Laboratories Private Limited, R & D Center Solid state forms of 2-[4-(2-{4-[1-(2-ethoxyethyl)-1h-benzimidazol-2-yl]-1-piperidinyl}ethyl)phenyl]-2-methylpropanoic acid and process for preparation thereof
CN107365298A (zh) * 2017-03-14 2017-11-21 罗欣生物科技（上海）有限公司 一种2‑甲基‑2’‑苯基丙酸衍生物的制备方法
CN109456316A (zh) * 2017-09-06 2019-03-12 万全万特制药江苏有限公司 一种比拉斯汀杂质的制备方法
ES2813561T3 (es) 2017-09-07 2021-03-24 Tiefenbacher Alfred E Gmbh & Co Kg Composición farmacéutica en comprimido que comprende bilastina
HUE053233T2 (hu) 2017-10-16 2021-06-28 Faes Farma Sa Bilasztint és mometanzont tartalmazó vizes készítmények
PL3641735T3 (pl) 2017-12-18 2021-09-06 Alfred E. Tiefenbacher (Gmbh & Co. Kg) Kompozycja farmaceutyczna tabletki zawierająca bilastynę w postaci 3 i rozpuszczalny w wodzie wypełniacz
EP3470062B1 (en) 2017-12-18 2020-10-28 Alfred E. Tiefenbacher (GmbH & Co. KG) Pharmaceutical tablet composition comprising bilastine polymorphic form 3 and magnesium aluminometasilicate
EA202091725A1 (ru) 2018-01-18 2020-10-12 Фаэс Фарма С.А. Офтальмические композиции, содержащие биластин, бета-циклодекстрин и по крайней мере одно желатинирующее вещество
CN109081827A (zh) * 2018-11-06 2018-12-25 北京天弘天达医药科技股份有限公司 一种比拉斯汀的制备方法及应用
EP3725298A1 (en) 2019-04-16 2020-10-21 Faes Farma, S.A. Stable and preserved pharmaceutical compositions of bilastine
WO2022023463A1 (en) 2020-07-30 2022-02-03 Faes Farma, S.A. Decongestant drug delivery system
CN112110893A (zh) * 2020-10-28 2020-12-22 山东齐环医药科技有限公司 一种比拉斯汀的制备方法
JP2023549381A (ja) 2020-11-18 2023-11-24 バイオファーマ・シナジーズ，エス．エル． 抗ヒスタミン活性化合物を含む口内分散性粉末組成物
WO2022135863A1 (en) 2020-12-23 2022-06-30 Biohorm, S.L. A non-micronized bilastine composition
PE20251070A1 (es) 2022-02-17 2025-04-10 Faes Farma Sa Composicion de bilastina para la administracion parenteral una vez al dia
WO2024224326A1 (en) * 2023-04-27 2024-10-31 Leiutis Pharmaceuticals Llp Liquid parenteral formulations of bilastine
WO2024224308A1 (en) * 2023-04-27 2024-10-31 Leiutis Pharmaceuticals Llp Liquid parenteral formulations of bilastine free of cyclodextrins

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8904174D0 (en) * 1989-02-23 1989-04-05 British Bio Technology Compounds
WO1991016313A1 (en) * 1990-04-13 1991-10-31 Smithkline Beecham Corporation Substituted benzimidazoles
ES2048109B1 (es) * 1992-07-20 1994-12-16 Espanola Prod Quimicos Procedimiento de preparacion de nuevos derivados piperidicos del bencimidazol.
ATE322899T1 (de) * 1992-08-03 2006-04-15 Sepracor Inc Terfenadin-carboxylat und die behandlung von allergischen erkrankungen
HU226037B1 (en) * 1993-06-25 2008-03-28 Aventis Inc Process for producing antihistaminic 4-diphenylmethyl/diphenylmethoxy piperidine derivatives and novel intermediates

Also Published As

Publication number Publication date
TR199700464A2 (xx) 1997-12-21
IN186319B (en:Method) 2001-08-04
PL188908B1 (pl) 2005-05-31
ATE264317T1 (de) 2004-04-15
US5877187A (en) 1999-03-02
LU91798I2 (fr) 2011-05-23
DE69728608D1 (de) 2004-05-19
PT818454E (pt) 2004-08-31
NO972525D0 (no) 1997-06-03
CN1105716C (zh) 2003-04-16
ZA974893B (en) 1997-12-30
DE122011000006I1 (de) 2011-06-16
EP0818454B1 (en) 2004-04-14
PL320358A1 (en) 1997-12-08
TR199700464A3 (tr) 1997-12-21
FR11C0023I1 (en:Method) 2011-08-19
NO313195B1 (no) 2002-08-26
HRP970307B1 (en) 2002-02-28
SI0818454T1 (en) 2004-08-31
HU9700997D0 (en) 1997-07-28
MXPA97004127A (es) 2005-07-25
JPH1059961A (ja) 1998-03-03
AU725700B2 (en) 2000-10-19
ES2124167B1 (es) 1999-09-16
HUP9700997A1 (hu) 1999-09-28
CZ289278B6 (cs) 2001-12-12
EP0818454A1 (en) 1998-01-14
ES2124167A1 (es) 1999-01-16
HRP970307A2 (en) 1998-04-30
DK0818454T3 (da) 2004-07-12
JP4218991B2 (ja) 2009-02-04
NO972525L (no) 1997-12-05
AR008386A1 (es) 2000-01-19
BR9703276A (pt) 2004-08-17
AU2467297A (en) 1997-12-11
TW438794B (en) 2001-06-07
NO2011008I2 (no) 2012-05-14
HU227598B1 (en) 2011-09-28
DE69728608T2 (de) 2005-04-21
CA2206754A1 (en) 1997-12-04
RU2182150C2 (ru) 2002-05-10
NO2011008I1 (no) 2011-06-06
CZ172397A3 (en) 1997-12-17
CN1176964A (zh) 1998-03-25
FR11C0023I2 (fr) 2012-03-16

Similar Documents

Publication Publication Date Title
CA2206754C (en) Benzimidazole derivatives with antihistaminic activity
EP0580541B1 (en) Piperidine derivatives of benzimidazole as antihistaminic and antiallergic agents
EP1513826B1 (en) New indolylpiperidine derivatives as potent antihistaminic and antiallergic agents
DE60218037T2 (de) Neue indolderivate mit affinität zum 5-ht6-rezeptor
US4430343A (en) Benzimidazole derivatives, process for the preparation thereof and pharmaceutical composition containing the same
JP2000512646A (ja) ５ｈｔ７受容体アンタゴニストとしてのスルホンアミド誘導体
WO2001021615A1 (en) Benzimidazole derivatives
JPH08109169A (ja) 非ペプチドタキキニン受容体拮抗物質
US9029357B2 (en) Benzazole derivatives as histamine H4 receptor ligands
IE904165A1 (en) Heterocyclic derivatives, their preparation and medicinal¹products containing them
FR2587029A1 (fr) Derives de benzimidazole, leur preparation et leur application en therapeutique
HU184797B (en) Process for preparing quinazoline derivatives
JP2003500488A (ja) 薬理活性を有するスルホンアミド化合物
US10106522B2 (en) Benzimidazole derivatives as antihistamine agents
TW202440553A (zh) 作為at2r拮抗劑的雜環化合物
JP2001502307A (ja) １，４―ジ置換ピペラジン
DE60000500T2 (de) Substituierte n-(piperidin-4-yl)-4h-3,1-benzo(thia/oxa)zin-2-amine, ihre herstellung und therapeutische verwendung
KR100494448B1 (ko) 항히스타민활성을가지는신규한벤조이미다졸유도체
IL96592A (en) Piperidine compounds their preparation and pharmaceutical compositions containing them
JPS63101380A (ja) 新規な２−メルカプトベンズイミダゾ−ル誘導体、それらの製造法およびそれらを有効成分として含有する抗潰瘍剤
WO1995025731A1 (fr) NOUVELLES 3-(φ-(4-BENZOYLPIPERIDINO)ALCOYL)-4H-BENZOPYRAN-4-ONES, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE
US20060122206A1 (en) Tetrahydropyridin-4-yl indoles with a combination of affinity for dopamine-D2 receptors and serotonin reuptake sites
HK1240223A1 (en) New benzimidazole derivatives as antihistamine agents
HK1240223B (en) New benzimidazole derivatives as antihistamine agents
JPH10120632A (ja) Ｎ−シクロアルキル−〔ω−（３，４−ジヒドロ−２−ナフタレニル）アルキル〕アミン誘導体及びそれを含有する医薬組成物

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry

Effective date: 20170605